2999-1726 Screening compound: N-[6-(acetylamino)-1,3-benzothiazol-2-yl]-4-[(cyclohexylcarbonyl)amino]benzamide

2999-1726 Screening compound: N-[6-(acetylamino)-1,3-benzothiazol-2-yl]-4-[(cyclohexylcarbonyl)amino]benzamide
2999-1726 Screening compound: N-[6-(acetylamino)-1,3-benzothiazol-2-yl]-4-[(cyclohexylcarbonyl)amino]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2999-1726
N-[6-(acetylamino)-1,3-benzothiazol-2-yl]-4-[(cyclohexylcarbonyl)amino]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2999-1726

Molecular Formula

C23H24N4O3S (C23 H24 N4 O3 S)

Compound Name

N-[6-(acetylamino)-1,3-benzothiazol-2-yl]-4-[(cyclohexylcarbonyl)amino]benzamide

IUPAC name

4-cyclohexaneamido-N-(6-acetamido-13-benzothiazol-2-yl)benzamide

SMILES

CC(Nc(cc1)cc2c1nc(NC(c(cc1)ccc1NC(C1CCCCC1)=O)=O)s2)=O

InChI

InChI=1S/C23H24N4O3S/c1-14(28)24-18-11-12-19-20(13-18)31-23(26-19)27-22(30)16-7-9-17(10-8-16)25-21(29)15-5-3-2-4-6-15/h7-13,15H,2-6H2,1H3,(H,24,28)(H,25,29)(H,26,27,30)

InChI Key

VOMBCMROPJMSKG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01893056

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.135

Distribution Coefficient, logD

4.131

Water Solubility, LogSw

-4.19

Polar Surface Area

79.636

Acid Dissociation Constant (pKa)

9.42

Base Dissociation Constant (pKb)

2.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.43

2999-1726 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Angiogenesis library (14822 compounds)

Anti-infective Library (19449 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Infections
  • Immune system
  • animal
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with 2999-1726 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2999-1726?
Check Price and Availability of 2999-1726, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2999-1726 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2999-1726
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2999-1726
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2999-1726 available by request